1-(4-bromophenyl)-N-(4-methoxyphenyl)-5-(4-methyl-2-pivalamidothiazol-5-yl)-1H-pyrazole-3-carboxamide

ID: ALA1098166

PubChem CID: 46221405

Max Phase: Preclinical

Molecular Formula: C26H26BrN5O3S

Molecular Weight: 568.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(NC(=O)c2cc(-c3sc(NC(=O)C(C)(C)C)nc3C)n(-c3ccc(Br)cc3)n2)cc1

Standard InChI:  InChI=1S/C26H26BrN5O3S/c1-15-22(36-25(28-15)30-24(34)26(2,3)4)21-14-20(31-32(21)18-10-6-16(27)7-11-18)23(33)29-17-8-12-19(35-5)13-9-17/h6-14H,1-5H3,(H,29,33)(H,28,30,34)

Standard InChI Key:  TVFKIHOEEAGATR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
    8.5500   -0.9394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3482   -0.7305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3981    0.0931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6274    0.3945    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1072   -0.2447    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0933    0.5373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8256    0.1575    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0561    1.3615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7512    1.8058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4822    1.4242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1769    1.8678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1401    2.6928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4028    3.0723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7111    2.6265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8347    3.1381    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5675    2.7592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2826   -0.2606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8598    0.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0357    0.4299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6364   -0.2930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0672   -1.0016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8899   -0.9824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8116   -0.3102    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    8.2484   -1.7055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4500   -1.9134    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.4009   -2.7369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1690   -3.0381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6927   -2.4006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5162   -2.4497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7058   -3.1813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7431   -4.0054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0480   -4.4498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4755   -4.3852    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3156   -4.0700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0852   -5.2739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3382   -4.8733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  2  0
 17 18  2  0
  8  9  1  0
 18 19  1  0
  4  5  1  0
 19 20  2  0
  9 10  2  0
 20 21  1  0
  5  1  1  0
 21 22  2  0
 22 17  1  0
 10 11  1  0
 20 23  1  0
 24 25  1  0
  1  2  2  0
 11 12  2  0
  3  6  1  0
 12 13  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  2  0
  1 24  1  0
 13 14  2  0
 28 29  1  0
 14  9  1  0
 26 30  1  0
  6  7  2  0
 30 31  1  0
 12 15  1  0
 31 32  1  0
  2  3  1  0
 31 33  2  0
 15 16  1  0
 32 34  1  0
  6  8  1  0
 32 35  1  0
  5 17  1  0
 32 36  1  0
M  END

Associated Targets(Human)

CFTR Tclin Cystic fibrosis transmembrane conductance regulator (2075 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 568.50Molecular Weight (Monoisotopic): 567.0940AlogP: 6.31#Rotatable Bonds: 6
Polar Surface Area: 98.14Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.90CX Basic pKa: CX LogP: 6.22CX LogD: 6.11
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -1.77

References

1. Ye L, Knapp JM, Sangwung P, Fettinger JC, Verkman AS, Kurth MJ..  (2010)  Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles.,  53  (9): [PMID:20373765] [10.1021/jm100235h]
2. Liessi N, Cichero E, Pesce E, Arkel M, Salis A, Tomati V, Paccagnella M, Damonte G, Tasso B, Galietta LJV, Pedemonte N, Fossa P, Millo E..  (2018)  Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools.,  144  [PMID:29272749] [10.1016/j.ejmech.2017.12.030]

Source